» Articles » PMID: 12466233

Divergent Mechanisms of Action of the Inflammatory Cytokines Interleukin 1-beta and Tumour Necrosis Factor-alpha in Mouse Cremasteric Venules

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2002 Dec 6
PMID 12466233
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

1. Protein synthesis dependency and the role of endogenously generated platelet activating factor (PAF) and leukotriene B(4) (LTB(4)) in leukocyte migration through interleukin-1beta (IL-1beta)- and tumour necrosis factor-alpha (TNFalpha)-stimulated mouse cremasteric venules was investigated using established pharmacological interventions and the technique of intravital microscopy. 2. Based on previously obtained dose-response data, 30 ng rmIL-1beta and 300 ng rmTNFalpha were injected intrascrotally (4 h test period) to induce comparable levels of leukocyte firm adhesion and transmigration in mouse cremasteric venules. 3. Co-injection of the mRNA synthesis inhibitor, actinomycin D (0.2 mg kg(-1)), with the cytokines significantly inhibited firm adhesion (49+/-13.6%) and transmigration (67.2+/-4.2%) induced by IL-1beta, but not TNFalpha. 4. In vitro, TNFalpha (1-100 ng ml(-1)), but not IL-1beta, stimulated L-selectin shedding and increased beta(2) integrin expression on mouse neutrophils, as quantified by flow cytometry. 5. The PAF receptor antagonist, UK-74,505 (modipafant, 0.5 mg kg(-1), i.v.), had no effect on adhesion induced by either cytokine, but significantly inhibited transmigration induced by IL-1beta (66.5+/-4.5%). 6. The LTB(4) receptor antagonist, CP-105,696 (100 mg kg(-1), p.o.), significantly inhibited both IL-1beta induced adhesion (81.4+/-15.2%) and transmigration (58.7+/-7.2%), but had no effect on responses elicited by TNFalpha. Combined administration of the two antagonists had no enhanced inhibitory effects on responses induced by either cytokine. 7. The data indicate that firm adhesion and transmigration in mouse cremasteric venules stimulated by IL-1beta, but not TNFalpha, is protein synthesis dependent and mediated by endogenous generation of PAF and LTB(4). Additionally, TNFalpha but not IL-1beta, can directly stimulate mouse neutrophils in vitro. The findings provide further evidence to suggest divergent mechanisms of actions of IL-1beta and TNFalpha, two cytokines often considered to act via common molecular/cellular pathways.

Citing Articles

Galectin-3: A Positive Regulator of Leukocyte Recruitment in the Inflamed Microcirculation.

Gittens B, Bodkin J, Nourshargh S, Perretti M, Cooper D J Immunol. 2017; 198(11):4458-4469.

PMID: 28438899 PMC: 5444525. DOI: 10.4049/jimmunol.1600709.


Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23.

Cash J, Bena S, Headland S, McArthur S, Brancaleone V, Perretti M EMBO Rep. 2013; 14(11):999-1007.

PMID: 23999103 PMC: 3818079. DOI: 10.1038/embor.2013.138.


Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.

Garcia C, Russo R, Guabiraba R, Fagundes C, Polidoro R, Tavares L PLoS Pathog. 2010; 6(11):e1001171.

PMID: 21079759 PMC: 2974216. DOI: 10.1371/journal.ppat.1001171.


Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1.

Woodfin A, Voisin M, Imhof B, Dejana E, Engelhardt B, Nourshargh S Blood. 2009; 113(24):6246-57.

PMID: 19211506 PMC: 2699241. DOI: 10.1182/blood-2008-11-188375.


Spatial regulation of inflammation by human aortic endothelial cells in a linear gradient of shear stress.

Tsou J, Gower R, Ting H, Schaff U, Insana M, Passerini A Microcirculation. 2008; 15(4):311-23.

PMID: 18464160 PMC: 2733907. DOI: 10.1080/10739680701724359.


References
1.
Kollias G, Douni E, Kassiotis G, Kontoyiannis D . The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis. 1999; 58 Suppl 1:I32-9. PMC: 1766575. DOI: 10.1136/ard.58.2008.i32. View

2.
Cominelli F, Dinarello C . Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease. Biotherapy. 1989; 1(4):369-75. DOI: 10.1007/BF02171013. View

3.
Thorlacius H, Vollmar B, Guo Y, Mak T, Pfreundschuh M, Menger M . Lymphocyte function antigen 1 (LFA-1) mediates early tumour necrosis factor alpha-induced leucocyte adhesion in venules. Br J Haematol. 2000; 110(2):424-9. DOI: 10.1046/j.1365-2141.2000.02162.x. View

4.
Schiff M . Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis. 2000; 59 Suppl 1:i103-8. PMC: 1766616. DOI: 10.1136/ard.59.suppl_1.i103. View

5.
Alloatti G, Penna C, Mariano F, Camussi G . Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol Regul Integr Comp Physiol. 2000; 279(6):R2156-63. DOI: 10.1152/ajpregu.2000.279.6.R2156. View